Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells

Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells
复制标题

DOI:
10.18632/oncotarget.2601
复制
发表时间:
2014-10
期刊:
影响因子:
--
通讯作者:
Hui-Chao Zhou;Jian-Hong Fang;Xuan Luo;Lei Zhang;Jin-E Yang;Chong Zhang;Shi‐Mei Zhuang
Hui-Chao Zhou;Jian-Hong Fang;Xuan Luo;Lei Zhang;Jin-E Yang;Chong Zhang;Shi‐Mei Zhuang
中科院分区:
--
文献类型:
--
作者:
Hui-Chao Zhou;Jian-Hong Fang;Xuan Luo;Lei Zhang;Jin-E Yang;Chong Zhang;Shi‐Mei Zhuang

文献摘要

相似文献

转移是肝细胞癌(HCC)快速复发和HCC患者生存差的原因。本研究表明,HCC组织中miR-100下调与静脉侵袭、TNM晚期、肿瘤结节无完整囊、细胞分化较差、无复发生存期较短显著相关。功能获得和功能丧失研究均表明,miR-100在体外显著抑制HCC细胞通过基质细胞迁移和侵袭的能力。小鼠原位异种移植模型分析进一步显示,与对照组相比,稳定表达mir -100的肝癌细胞异种移植的肺转移率显著降低。随后的研究发现,miR-100通过结合异戊酰半胱氨酸羧基甲基转移酶(ICMT)和ras相关的C3肉毒毒素底物1 (Rac1)的3′- utr直接抑制其表达,进而抑制板足形成和基质金属肽酶2 (MMP2)的激活。此外,ICMT和Rac1的下调可表型化miR-100的抗转移作用,而组成活性的Rac1 (Q61L)的过表达可拮抗miR-100的功能。综上所述,miR-100通过消除ICMT-Rac1信号传导抑制HCC细胞的转移。miR-100的下调有助于HCC转移,miR-100的恢复是癌症治疗的潜在策略。
Metastasis is responsible for rapid recurrence of hepatocellular carcinoma (HCC) and poor survival of HCC patients. Here we showed that miR-100 downregulation in HCC tissues was significantly associated with venous invasion, advanced TNM stage, tumor nodule without complete capsule, poorer cell differentiation, and shorter recurrence-free survival. Both gain- and loss-of-function studies showed that miR-100 dramatically suppressed the ability of HCC cells to migrate and to invade through Matrigel in vitro. Analyses using mouse orthotopic xenograft model further revealed that xenografts of miR-100-stable-expressing HCC cells displayed a significant reduction in pulmonary metastasis, compared with control group. Subsequent investigations revealed that miR-100 directly inhibited the expression of isoprenylcysteine carboxyl methyltransferase (ICMT) and ras-related C3 botulinum toxin substrate 1 (Rac1) by binding to their 3′-UTRs, and in turn suppressed lamellipodia formation and matrix metallopeptidase 2 (MMP2) activation. Furthermore, knockdown of ICMT and Rac1 phenocopied the anti-metastasis effect of miR-100, whereas overexpression of the constitutively active Rac1 (Q61L) antagonized the function of miR-100. Taken together, miR-100 represses metastasis of HCC cells by abrogating the ICMT-Rac1 signaling. Downregulation of miR-100 contributes to HCC metastasis and the restoration of miR-100 is a potential strategy for cancer therapy.